None listed
Conditions
Interventions
None listed
Sponsors
Koera University Guro Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Prospectively Retrospective Group Inclusion Criteria: 1. Patients with pediatric inflammatory bowel disease (Crohn's disease, ulcerative colitis, unclassified IBD) who have been diagnosed and treated, with documented medical records. 2. Patients diagnosed at or before the age of 18, including those who are currently over 18 years old. ? Prospective Group Inclusion Criteria: 1. Pediatric and adolescent patients aged 18 years or younger newly diagnosed or awaiting diagnosis with Crohn's disease, ulcerative colitis, or unclassified IBD. 2. Patients who were diagnosed with the conditions mentioned in 1) before the study period and are currently under follow-up, starting a new biologic therapy. 3. ndividuals who have provided written consent for participation (parental or legal guardian consent is mandatory). Partial consent is allowed (e.g., providing only clinical information or specific samples).
Exclusion criteria
Exclusion criteria: 1. Behçet's disease. 2. In cases where there is a concern for bleeding or other complications during the collection of human-derived materials (intestinal tissue), exclusion from tissue collection will be determined by the joint decision of the institutional collaborators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical severity score | — |
Secondary
| Measure | Time frame |
|---|---|
| endoscopic score (SES-CD, UCEIS);surgery | — |
Countries
Korea, Republic of
Contacts
Public ContactJung Ok Shim
Koera University Guro Hospital
Outcome results
None listed